id: NEW:nafld_prevalence_to_NEW:hepatocellular_carcinoma_incidence
name: Non-alcoholic fatty liver disease prevalence â†’ Hepatocellular carcinoma incidence
from_node:
  node_id: NEW:nafld_prevalence
  node_name: Non-alcoholic fatty liver disease prevalence
to_node:
  node_id: NEW:hepatocellular_carcinoma_incidence
  node_name: Hepatocellular carcinoma incidence
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: NAFLD develops due to hepatic fat accumulation exceeding 5% of liver weight
  in the absence of significant alcohol consumption, driven by metabolic dysfunction
  including insulin resistance and obesity'
- 'Step 2: Chronic hepatic steatosis progresses to non-alcoholic steatohepatitis (NASH)
  with inflammation, hepatocyte injury, and oxidative stress'
- 'Step 3: Persistent inflammation and hepatocyte damage trigger fibrogenic pathways,
  leading to progressive liver fibrosis and cirrhosis'
- 'Step 4: The chronically inflamed and fibrotic liver microenvironment promotes genomic
  instability, aberrant cell proliferation, and impaired tumor suppression mechanisms'
- 'Step 5: Accumulated genetic mutations and epigenetic alterations in hepatocytes
  lead to malignant transformation and development of hepatocellular carcinoma'
evidence:
  quality_rating: A
  n_studies: 237
  primary_citation: 'Jie Li et al. 2019. Prevalence, incidence, and outcome of non-alcoholic
    fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    The lancet. Gastroenterology & hepatology.'
  supporting_citations: []
description: Non-alcoholic fatty liver disease (NAFLD) increases the incidence of
  hepatocellular carcinoma through a progressive pathway involving chronic hepatic
  inflammation, steatohepatitis, fibrosis, and eventual cirrhosis. This systematic
  review and meta-analysis of 237 studies encompassing over 13 million participants
  in Asia demonstrated that NAFLD patients have an annual hepatocellular carcinoma
  incidence rate of 1.8 cases per 1000 person-years. The rising prevalence of NAFLD
  over time (from 25% to 34% between 1999-2017) indicates an increasing burden of
  NAFLD-related hepatocellular carcinoma.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 1.8
    type: incidence_rate
    ci_lower: 0.8
    ci_upper: 3.1
  p_value: null
  sample_size: 13044518
moderators:
- name: age
  direction: strengthens
  strength: moderate
  description: Older individuals with NAFLD are at higher risk for hepatocellular
    carcinoma development
- name: sex
  direction: strengthens
  strength: moderate
  description: Male sex is associated with higher risk of NAFLD-related hepatocellular
    carcinoma
- name: obesity
  direction: strengthens
  strength: strong
  description: Obesity is a key driver of NAFLD progression and increases hepatocellular
    carcinoma risk
- name: time_period
  direction: strengthens
  strength: moderate
  description: NAFLD prevalence increased significantly over time (25.28% in 1999-2005
    to 33.90% in 2012-2017), suggesting increasing HCC burden
